---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-014884"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2023-02-27T23:59:59+00:00"
generated_at: "2026-06-18T23:13:55.506499+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Oramed Pharmaceuticals adopts amended bylaws with new stockholder consent rules and indemnification limits

## Summary
- Board adopted Fourth Amended and Restated By-laws effective February 23, 2023.
- New rules for stockholder action by written consent, including record date and independent inspector of election.
- Limits indemnification for proceedings commenced by the person unless board-authorized.
- Reduces indemnification by amounts collected from other entity for service at another entity.
- Requires affirmative vote of majority of outstanding shares to alter, amend, or repeal bylaws.

## SEC filing metadata
- accession: 0001213900-23-014884
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2023-02-27T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000121390023014884/0001213900-23-014884-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000121390023014884/ea174308-8k_oramed.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-014884
- JSON: https://secwatch.observer/filing/0001213900-23-014884.json
- Plain text: https://secwatch.observer/filing/0001213900-23-014884.txt

## Key facts
- Governance Changes
  ORAMED PHARMACEUTICALS INC.: Adopted Fourth Amended and Restated By-laws implementing rules for stockholder action by written consent, eliminating outdated provisions, limiting indemnification, and requiring majority vote for amendments (effective 2023-02-23).
  - Change: bylaw amendment
  - Effective: 2023-02-23
  source text: On February 23, 2023, the board of directors of Oramed Pharmaceuticals Inc. (the “Company”) adopted Fourth Amended and Restated By-laws (the “By-laws”), which became effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1176309/000121390023014884/0001213900-23-014884-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.